These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 526329)

  • 1. The metabolism of 2'-deoxycoformycin by L1210 cells in vitro.
    Venner PM; Glazer RI
    Biochem Pharmacol; 1979 Nov; 28(21):3239-42. PubMed ID: 526329
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmokinetics of 2'-deoxycoformycin in normal and L1210 leukemic mice.
    McConnell WR; Furner RL; Hill DL
    Drug Metab Dispos; 1979; 7(1):11-3. PubMed ID: 35319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by 2'-deoxycoformycin of the inhibitory effect of xylosyladenine on nuclear RNA synthesis in L1210 cells in vitro.
    Peale AL; Glazer RI
    Biochem Pharmacol; 1978; 27(21):2543-7. PubMed ID: 728208
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo.
    Agarwal RP
    Cancer Res; 1979 Apr; 39(4):1425-7. PubMed ID: 421226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.
    King FG; Dedrick RL
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):519-34. PubMed ID: 6977636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.
    Rogler-Brown T; Agarwal RP; Parks RE
    Biochem Pharmacol; 1978; 27(19):2289-96. PubMed ID: 569482
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine metabolism in cultured lymphoid cells.
    Harrap KR; Paine RM
    Adv Enzyme Regul; 1976; 15():169-93. PubMed ID: 1030182
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
    Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG; Wohlhueter RM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphorylation of "tricyclic nucleoside" by adenosine kinases from L1210 cells and HEp-2 cells.
    Bennett LL; Allan PW; Chang CH
    Biochem Pharmacol; 1983 Sep; 32(17):2601-2. PubMed ID: 6311222
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of interleukin-2 messenger RNA in mouse lymphocytes by 2'-deoxycoformycin and adenosine metabolites.
    Cohen MB; Glazer RI
    Ann N Y Acad Sci; 1985; 451():180-7. PubMed ID: 3878116
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of the phosphorylation of nonhistone chromosomal proteins by cordycepin and xylosyladenine in L1210 cells in vitro.
    Legraverend M; Glazer RI
    Mol Pharmacol; 1978 Nov; 14(6):1130-5. PubMed ID: 310509
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme inhibition titration assay for 2'-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats.
    Chassin MM; Adamson RH; Zaharevitz DW; Johns DG
    Biochem Pharmacol; 1979 Jun; 28(12):1849-55. PubMed ID: 454456
    [No Abstract]   [Full Text] [Related]  

  • 17. 2'-deoxycoformycin. A new anticancer agent.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical consequences of treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Paine RM; Smyth JF; Harrap KR
    Adv Exp Med Biol; 1979; 122B():365-71. PubMed ID: 317569
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.